Stabilization of cyclin D1 mRNA via the phosphatidylinositol 3-kinase pathway in MCF-7 human breast cancer cells

Journal of Endocrinology

Volumn 166, Issue 2, 2000, Pages 329-338

  Dufourny, B ^a   Van Teeffelen, H A A M ^a   Hamelers, I H L ^a   Sussenbach, J S ^a   Steenbergh, P H ^a  

^a UTRECHT UNIVERSITY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; CYCLIN D1; EPIDERMAL GROWTH FACTOR; ESTRADIOL; MESSENGER RNA; MYC PROTEIN; PHORBOL 13 ACETATE 12 MYRISTATE; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHATIDYLINOSITOL 3 KINASE INHIBITOR; PROTEIN C FOS; STRESS ACTIVATED PROTEIN KINASE; UNCLASSIFIED DRUG;

ARTICLE; BREAST CANCER; CANCER HORMONE THERAPY; ENZYME INHIBITION; ENZYME STABILITY; HALF LIFE TIME; HUMAN; HUMAN CELL; HUMAN TISSUE; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; STEADY STATE; TRANSCRIPTION REGULATION;

EID: 0033839158     PISSN: 00220795     EISSN: None     Source Type: Journal    
DOI: 10.1677/joe.0.1660329     Document Type: Article

References (48)

1. Transforming p21 ras mutants and c-Ets-2 activate the cyclin D1 promoter through distinguishable regions
2. 17β-Estradiol induces cyclin D1 gene transcription, p36D1-p34cdk4 complex activation and p105Rb phosphorylation during mitogenic stimulation of G1-arrested human breast cancer
3. Wortmannin is a potent phosphatidylinositol 3-kinase inhibitor: The role of phosphatidylinositol 3,4,5-trisphosphate in neutrophil responses
4. Association of IRS-1 with the insulin receptor and the phophatidylinositol 3'-kinase
5. Binding of the ras activator son of sevenless to insulin receptor substrate-1 signaling complexes
6. Mitogenic stimulation of human breast cancer cells in a growth factor-defined medium: Synergistic action of insulin and estrogen
7. Protein kinase B (c-Akt) in phosphatidylinositol-3-OH kinase signal transduction
8. Activity of a 40 kDa RNA-binding protein correlates with MYCN and c-fos mRNA stability in human neuroblastoma
9. Phosphatidylinositol 3-kinase activation is required for insulin stimulation of pp70 S6 kinase, DNA synthesis, and glucose transporter translocation
10. The 70 kDa S6 kinase complexes with and is activated by the Rho family G proteins Cdc42 and Rac1
11. How MAP kinases are regulated
12. A synthetic inhibitor of the mitogen-activated protein kinase cascade
13. Mitogenic signaling of insulin-like growth factor I in MCF-7 human breast cancer cells requires phosphatidylinositol 3-kinase and is independent of mitogen-activated protein kinase
14. Stabilization of granulocyte-macrophage colony-stimulating factor RNA in a human eosinophil-like cell line requires the AUUUA motifs
15. Induction of cyclin D1 overexpression by activated ras
16. Rapamycin inhibition of the G1 to S transition is mediated by effects on cyclin D1 mRNA and protein stability
17. Enhanced stability of interleukin-2 mRNA in MLA 144 cells. Possible role of cytoplasmic AU-rich sequence-binding proteins
18. A small deletion in the 3'-untranslated region of the cyclin D1 PRAD1/bd-1 oncogene in a patient with chronic lymphocytic leukemia
19. Insulin-like growth factor I rapidly stimulates tyrosine phosphorylation of a Mr 185 000 protein in intact cells
20. Differential responsiveness of human breast cancer cell lines MCF-7 and T47D to growth factors and 17β-estradiol
21. Induction of rapid IL-1 beta mRNA degradation in THP-1 cells mediated through the AU-rich region in the 3'UTR by a radicicol analogue
22. Inhibition of DNA synthesis by a farnesyltransferase inhibitor involves inhibition of the p70(s6k) pathway
23. A truncated cyclin D1 gene encodes a stable mRNA in a human breast cancer cell line
24. Ras transformation results in an elevated level of cyclin D1 and acceleration of G1 progression in NIH 3T3 cells
25. Regulation of EGF-receptor expression by EGF and TGF alpha in epidermoid cancer cells is cell type-specific
26. Synergy between AUUUA motif disruption and enhancer insertion results in autocrine transformation of interleukin-3-dependent hematopoietic cells
27. c-jun N-terminal kinase is involved in AUUUA-mediated interleukin-3 mRNA turnover in mast cells
28. A novel cyclin encoded by a bc/1-linked candidate oncogene
29. Cyclin D expression is controlled post-transcriptionally via a phosphatidylinositol 3-kinase Akt-dependent pathway
30. Trancriptional regulation during the mammalian cell cycle
31. IRS-1 activates phosphatidyllnositol 3'-kinase by associating with src homology 2 domains of p85
32. Cyclin-dependent protein kinases: Key regulators of the eukaryotic cell cycle
33. Functional characterization of a non-AUUUA AU-rich element from the c-jun proto-oncogene mRNA: Evidence for a novel class of AU-rich elements
34. Rapamycin-induced inhibition of the 70-kilodalton S6 protein kinase
35. mRNA stability in mammalian cells
36. Transcriptional control of the cell cycle
37. Gene rearrangement and overexpression of PRAD1 in lymphoid malignancy with t(11;14)(q13;q32) translocation
38. Insulin and insulin-like growth factor-I stimulate a common endogenous phosphoprotein substrate (pp185) in intact neuroblastoma cells
39. The function of GRB2 in linking the insulin receptor to ras signaling pathways
40. The SH2/SH3 domain-containing protein GRB2 interacts with tyrosine-phosphorylated IRS1 and Shc: Implications for insulin control of ras signalling
41. A specific inhibitor of phosphatidylinositol 3-kinase, 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one (LY294002)
42. Posttranscriptional regulation of protein expression in human epithelial carcinoma cells by adenine-uridine-rich elements in the 3'-untranslated region of tumor necrosis factor-alpha messenger RNA
43. Angiotensin II activation of cyclin D1-dependent kinase activity
44. The retinoblastoma protein and cell cycle control
45. Enhanced protein stability: A novel mechanism of D-type cyclin over-abundance identified in human sarcoma cells
46. Characterization of a candidate bcl-1 gene
47. Human D-type cyclin
48. Cyclin D1 triggers autonomous growth of breast cancer cells by governing cell cycle exit